Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$16.76.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in Aurinia Pharmaceuticals. This rating has held steady since July 2022, when it changed from a Buy consensus rating.